Moderna eyes Omicron-specific jab in 2022

By Georgie Moore and Dominic Giannini
Updated January 27 2022 - 8:41am, first published 8:35am
Pharmaceutical company Moderna is testing its Omicron-specific COVID-19 booster vaccine.

Pharmaceutical company Moderna aims to have its Omicron-specific COVID-19 booster vaccine on the market by the third quarter of 2022.

Advertisement

Ad